429 results on '"Burdach, S."'
Search Results
2. Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
3. Targeting the EWS–FLI1 transcription factor in Ewing sarcoma
4. High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients
5. No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
6. Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases
7. TARGETING THE GRAFT-VERSUS-TUMOR EFFECT OF DLI BY REGIONAL HYPERTHERMIA TO THE TUMOR COMPARTMENT: PH-AB144
8. ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED RHABDOMYOSARCOMA: A RETROSPECTIVE ASSESSMENT: PH-AB118
9. CLINICAL IMPACT OF POST-TRANSPLANT CHIMERISM MONITORING IN CD33/34 BONE MARROW SUBPOPULATIONS AND WHOLE PERIPHERAL BLOOD IN PEDIATRIC AML: PROSPECTIVE COMPARISON OF HIGHLY SENSITIVE REAL TIME SEQUENCE POLYMORPHISM PCR VERSUS GOLD-STANDARD STR-PCR: PH-O097
10. TCR TRANSGENIC ALLO-RESTRICTED T CELLS DIRECTED AGAINST EWING SARCOMA ASSOCIATED ANTIGENS EZH2 AND CHM1: PH-O094
11. Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy
12. Growth factors and hemostasis: differential effects of GM-CSF and G-CSF on coagulation activation – laboratory and clinical evidence
13. Panniculitis, pancreatitis and very severe aplastic anemia in childhood: a challenge to treat
14. Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants
15. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis – Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation
16. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies
17. Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T-cells: O310
18. Intensified pre-emptive immunotherapy in childhood acute myeloid leukaemia patients showing evidence of mixed chimerism after allogeneic stem cell transplantation: O171
19. First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham–Stout) with bevacizumab in a child
20. 7.P.38 EZH2 IS A MEDIATOR OF EWS/FLI1 DRIVEN TUMOR GROWTH AND METASTASIS BLOCKING ENDOTHELIAL AND NEUROECTODERMAL DIFFERENTIATION
21. 3.P.34 SCLEROSING EPITHELOID FIBROSARCOMA OF THE BONE: A CASE REPORT AND SURVEY OF THE LITERATURE
22. Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications
23. CD25 Blockade protects T Cells from Activation-induced Cell Death (AICD) via Maintenance of TOSO Expression
24. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation
25. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation
26. German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
27. Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study
28. Risk factors for capillary leakage syndrome after bone marrow transplantation
29. Decreased interleukin 10 and increased interferon-γ production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation
30. Thrombocytopenia and complement activation under recombinant TNFα/IFNγ therapy in man
31. Lethal Double Infection With Acremonium Strictum and Aspergillus Fumigatus During Induction Chemotherapy in a Child With ALL
32. A long-term evaluation of the potency of a specific cellular transplantation procedure as a therapeutic strategy after traumatic brain injury: OP86
33. Definition of a new score for severity of generalizedNeisseria meningitidis infection
34. Long-term Haematopoietic Reconstitution and Survival without Interleukin-7 in a Murine Syngeneic Bone Marrow Transplantation Model
35. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours
36. Molekulargenetischer Nachweis der t(11;22)(q24;q12)-Translokation in Ewing-Sarkomen und malignen peripheren neuroektodermalen Tumoren (MPNT)
37. Interferonγ and tumour necrosis factorα induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro
38. Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation
39. Fatal late-onset EBV-associated post transplant lymphoproliferative disease after umbilical cord blood transplantation due to persistent mixed chimerism and severe delay in T-cell recovery in a patient with Omenn's syndrome
40. Unrelated cord blood transplantation in an infant with severe multisystem Langerhans cell histiocytosis: clinical outcome, engraftment and culture of monocyte-derived dendritic cells
41. ICOS: A New Costimulatory Ligand/Receptor Pair and Its Role in T-Cell Activion
42. Conditional expression of AML1-ETO in U-937 cells: Effects on expression of putative target genes: P455
43. High-Dose Therapy for Patients With Primary Multifocal and Early Relapsed Ewing’s Tumors: Results of Two Consecutive Regimens Assessing the Role of Total-Body Irradiation
44. Treatment with cyclosporin A in a patient with Omenn’s syndrome
45. Unusual presentation of central nervous system relapse with oculomotor nerve palsy in a case of CD56-positive acute myeloid leukemia following allogeneic stem cell transplantation
46. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors: An update after long-term follow-up from two centers of the European Intergroup Study EICESS
47. Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantation
48. Reversible brain MRI changes in acyclovir neurotoxicity
49. High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT)
50. Glycogen storage disease type Ib: Infectious complications and measures for prevention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.